A Replacement Diet with KAMUT® Khorasan Wheat Indicates Benefits for Study Participants with Fibromyalgia
MISSOULA, Mont., June 20, 2022 /PRNewswire-PRWeb/ -- A recent study conducted by the University of Florence Department of Experimental and Clinical Medicine in Italy, and published in the World Journal of Gastroenterology (WJG), indicated benefits of a dietary treatment when applied to the clinical care of patients with fibromyalgia. Aligned with recent guidelines suggesting that an optimal strategy to treat fibromyalgia includes a combination of pharmacological and non-pharmacological treatment, in results of this study participants that underwent a substitute diet with ancient KAMUT® khorasan wheat reported significant improvement in widespread pain, quality of sleep, and impact of the disease. Moreover, a KAMUT® khorasan wheat-based diet resulted in beneficial gut microbiota composition and functional modifications as well as improvement in reported symptoms.
- The study indicated improvement in pain, sleep, gut microbiota, inflammation, and the impact of fibromyalgia in participants that incorporated KAMUT khorasan wheat products in their diet.
- Moreover, a KAMUT khorasan wheat-based diet resulted in beneficial gut microbiota composition and functional modifications as well as improvement in reported symptoms.
- Effectiveness of a Khorasan Wheat-Based Replacement on Pain Symptoms and Quality of Life in Patients with Fibromyalgia.
- Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia.